Skip to content

Clinical trials

Observational Lung Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Spain Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20121
20132
20144
20151
20163
20172
20191
20204
20213
20225
20234
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting8
Unknown status4
Active, not recruiting2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación GECP6
AstraZeneca5
Bristol-Myers Squibb2
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal2
Amgen1
Ana Broseta Lleó1
Biobizkaia Health Research Institute1
Corporacion Parc Tauli1
European Organisation for Research and Treatment of Cancer - EORTC1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms38
Carcinoma, Non-Small-Cell Lung7
Breast Neoplasms3
COVID-193
Colorectal Neoplasms2
Coronavirus Infections2
Neoplasm Metastasis2
Neoplasms2
Ovarian Neoplasms2
Prostatic Neoplasms2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.